Relation of Antiphospholipid Antibodies to Postmortem Brain Infarcts in Older Persons Running title: Arvanitakis et al.; Antiphospholipid antibodies and brain infarcts

Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago, IL; Dept of Neurological Sciences, Rush University Medical Center, Chicago, IL; Dept of Neurology, University of Texas Health Science Center at San Antonio, TX; Dept of Pathology, Montefiore Medical Center, Bronx, NY; Dept of Pathology, Rush University Medical Center, Chicago, IL; Depts of Neurology and Emergency Medicine, State University of New York Downstate Medical Center, Brooklyn, NY and Dept of Neurology, Kings County Hospital Center, Brooklyn, NY

[1]  R. Cantello,et al.  Revisiting the Molecular Mechanism of Neurological Manifestations in Antiphospholipid Syndrome: Beyond Vascular Damage , 2014, Journal of immunology research.

[2]  L. Arnaud,et al.  Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: an international and collaborative meta-analysis. , 2014, Autoimmunity reviews.

[3]  M. Balasubramanian,et al.  Evolution of antiphospholipid antibody syndrome. , 2012, The American journal of forensic medicine and pathology.

[4]  S. Leurgans,et al.  Antiphospholipid Antibodies, Brain Infarcts, and Cognitive and Motor Decline in Aging (ABICMA): Design of a Community-Based, Longitudinal, Clinical-Pathological Study , 2012, Neuroepidemiology.

[5]  J. Schneider,et al.  Overview and findings from the religious orders study. , 2012, Current Alzheimer research.

[6]  J. Schneider,et al.  Overview and findings from the rush Memory and Aging Project. , 2012, Current Alzheimer research.

[7]  S. Leurgans,et al.  Microinfarct Pathology, Dementia, and Cognitive Systems , 2011, Stroke.

[8]  Y. Ohkura,et al.  Multiple aortic aneurysms complicated by a rupture in the systemic lupus erythematosus: a case report. , 2008, Pathology, research and practice.

[9]  J. Piette,et al.  Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients , 2008, Annals of the rheumatic diseases.

[10]  M. Leavitt,et al.  Department of Health and Human Services , 2007, Disaster Medicine and Public Health Preparedness.

[11]  L. Werneck,et al.  Clinical, neurovascular and neuropathological features in Sneddon's syndrome. , 2007, Arquivos de neuro-psiquiatria.

[12]  Y. Shoenfeld,et al.  International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) , 2006, Journal of thrombosis and haemostasis : JTH.

[13]  D. Walker,et al.  Catastrophic antiphospholipid syndrome: A rare cause of disseminated microvascular thrombotic injury – a case report with pathological and molecular correlative studies , 2005, Pathology international (Print).

[14]  R. D'Agostino,et al.  Anticardiolipin Antibodies and Risk of Ischemic Stroke and Transient Ischemic Attack: The Framingham Cohort and Offspring Study , 2004, Stroke.

[15]  R. Sacco,et al.  Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. , 2004, JAMA.

[16]  J. Schneider,et al.  Relation of cerebral infarctions to dementia and cognitive function in older persons , 2003, Neurology.

[17]  D. Tanné,et al.  Anticardiolipin Antibodies and Mortality in Patients with Ischemic Stroke: A Prospective Follow-Up Study , 2002, Neuroepidemiology.

[18]  S. Kittner,et al.  &bgr;2-Glycoprotein 1–Dependent Anticardiolipin Antibodies and Risk of Ischemic Stroke and Myocardial Infarction: The Honolulu Heart Program , 2001, Stroke.

[19]  A. Biasiolo,et al.  Effect of Anti-β2Glycoprotein I Lupus Anticoagulants on Fibrin Polymerization and Fibrinolysis , 2000, Autoimmunity.

[20]  J. Rand,et al.  Pregnancy loss in the antiphospholipid-antibody syndrome--a possible thrombogenic mechanism. , 1997, The New England journal of medicine.

[21]  P. Gatenby,et al.  Focal cerebral ischemia and antiphospholipid antibodies: a case for cardiac embolism , 1994, Acta neurologica Scandinavica.

[22]  P. Ford,et al.  Clinicopathologic correlations of antiphospholipid antibodies. An autopsy study. , 1994, Archives of pathology & laboratory medicine.

[23]  M. Hughson,et al.  Thrombotic cerebral arteriopathy in patients with the antiphospholipid syndrome. , 1993, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[24]  M. Backonja,et al.  Neuropathologic findings in multi-infarct dementia associated with anticardiolipin antibody. Evidence for endothelial injury as the primary event. , 1992, Arthritis and rheumatism.

[25]  F. Gotoh,et al.  Stroke in systemic lupus erythematosus. , 1990, Stroke.

[26]  K. Welch,et al.  Cerebrovascular and neurologic disease associated with antiphospholipid antibodies , 1990, Neurology.

[27]  W. Chan,et al.  Increased risk of ischemic stroke in patients with systemic lupus erythematosus: a nationwide population-based study. , 2012, Internal medicine.

[28]  E. Harris,et al.  The antiphospholipid syndrome , 1995, Clinical reviews in allergy & immunology.